Abbott Laboratories (ABT)
$101.82+2.23%Close
SELLRECOVERY · day 2
Key stats
Short interest · FINRA settlement 2026-09-30
52-week IV14.6%–53.0%
- Market cap
- $177.4B
- Beta
- 0.58
- Div yield
- 3.17%
- P/E (TTM)
- 31.57
- IV-%ile
- 96
- IV ATM
- 39.9%
- Short % float
- 0.79%
- Days to cover
- 1.5
- SI change
- -31.5%
- 1W
- +1.72%
- 1M
- -0.13%
- vs SPY 1W
- +1.30%
- vs SPY 1M
- -2.19%
Industry peers
FMP comparable companies · ranked by market cap
- JNJSELLJohnson & Johnson$618.1BBEARQ 22$256.48+0.88%
- TMOBUYThermo Fisher Scientific Inc.$241.1BBULLQ 18$651.98+0.64%
- DHRBUYDanaher Corporation$152.9BRECOVERYQ 36$217.46+0.63%
- MDTSELLMedtronic Plc$112.3BRECOVERYQ 14$87.75+3.90%
- SYKSELLStryker Corporation$106.2BRECOVERYQ 25$276.97+1.90%
- BSXSELLBoston Scientific Corporation$62.5BRECOVERYQ 6$42.04+2.60%
- BDXBUYBecton, Dickinson and Company$50.4BBULLQ 21$182.75+2.80%
- EWSELLEdwards Lifesciences Corporation$48.5BBEARQ 18$84.24+1.38%
- GEHCBUYGE HealthCare Technologies Inc.$29.0BRECOVERYQ 6$64.22+3.04%
- SMMNYSiemens Healthineers AG$24.2B$21.64
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 64
- VALUE
- 36
- GROWTH
- 57
- GARP
- 56
- TYPE
- Dividend Compounder
Composite of Value · Growth · GARP
ROIC6.3%
REV YoY-
ROE10.5%
EPS YoY-
ROA5.0%
GROSS57
OP17
NET12
[VALUATION]
P/E TTM31.57
P/E FWD18.32
SECTOR PE20.54
INDUSTRY PE22.84
P/B3.35
P/FCF-
EV/EBITDA19.85
EV/EBIT-
PEG1.84
FCF YIELD-
RISK
INT COV-
D/E63.80
ALTMAN Z-
CURR RATIO1.38
ND/EBITDA-
BETA0.58
Company news
FAQ
- What is LOPJLB’s current signal on ABT?
- LOPJLB’s latest quantitative signal on Abbott Laboratories (ABT) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is ABT in?
- Abbott Laboratories (ABT) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Abbott Laboratories (ABT) do?
- Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmac…